Comprehensive Cancer Centers notes a study showing a promising potential new pancreatic cancer treatment, along with details about the disease and its risk factors.
The physicians at Comprehensive Cancer Centers are interested in recent news of a new drug that is showing promising results in the treatment of pancreatic cancer. Pancreatic cancer is one of the most serious forms of cancer, largely because it often develops silently and is usually diagnosed at an advanced stage, leaving successful treatment not always a guarantee.
The pancreas is a small but essential organ located deep in the abdomen, behind the stomach. It plays a dual role in the body, helping regulate blood sugar through hormone production while also releasing enzymes that aid in digestion. When cancer forms in this organ, it can disrupt both of these critical functions, often without causing obvious symptoms at first.
Most pancreatic cancers begin in the exocrine cells, which are responsible for producing digestive enzymes. The most common type is pancreatic ductal adenocarcinoma, which starts in the ducts that carry these enzymes out of the pancreas. There are also fewer common forms that arise in the endocrine cells, known as neuroendocrine tumors, which behave differently and often have a better prognosis. Despite these differences, the general term pancreatic cancer is usually associated with the more aggressive exocrine form.
Why Pancreatic Cancer Is Difficult to Detect Early
One of the main challenges with pancreatic cancer is that early symptoms are vague or nonexistent. The pancreas is located deep within the body, so small tumors do not easily cause noticeable changes. As a result, many people are diagnosed only after the disease has spread to nearby organs or distant parts of the body. When symptoms do appear, they can include abdominal pain that radiates to the back, unexplained weight loss, loss of appetite, fatigue, and digestive problems. Another hallmark symptom is jaundice, a yellowing of the skin and eyes, which occurs when a tumor blocks the bile duct and causes a buildup of bilirubin in the body.
Risk Factors for Pancreatic Cancer
The causes of pancreatic cancer are not fully understood, but several risk factors have been identified. Smoking is one of the most significant and well-established risk factors, with smokers being much more likely to develop the disease than non-smokers. Chronic inflammation of the pancreas, known as Pancreatitis, is another important contributor, particularly when it occurs over many years. Obesity, long-standing diabetes, and a family history of pancreatic cancer also increase risk. In some cases, inherited genetic mutations play a role, especially in families with known cancer syndromes.
At the biological level, pancreatic cancer develops through a series of genetic mutations that allow cells to grow uncontrollably and evade normal regulatory mechanisms. Mutations in genes such as KRAS, TP53, and CDKN2A are commonly found in pancreatic tumors. These changes disrupt the normal balance between cell growth and cell death, leading to the formation of malignant tissue. Over time, cancer cells can invade nearby structures, including blood vessels and nerves, and eventually spread to other organs such as the liver or lungs.
How Pancreatic Cancer Is Diagnosed
Diagnosis of pancreatic cancer typically involves a combination of imaging tests and tissue sampling. Because symptoms often are nonspecific, doctors may first use imaging techniques like CT scans, MRI scans, or endoscopic ultrasound to visualize the pancreas and identify any abnormal growths. If a suspicious mass is found, a biopsy is usually performed to confirm the diagnosis. Blood tests may be used to look for tumor markers, such as CA 19-9, although these are not definitive on their own and are mainly used to monitor disease progression rather than detect it early.
Staging is an important step after diagnosis, as it determines how far the cancer has spread and helps guide treatment decisions. Early-stage pancreatic cancer is confined to the pancreas and may be eligible for surgical removal. Unfortunately, only a small percentage of patients are diagnosed at this stage. More commonly, the cancer has already spread locally or to distant organs, making surgery more difficult or impossible.
Surgery and Standard Treatments for Pancreatic Cancer
Surgery offers the best chance for long-term survival, particularly when the tumor can be completely removed. The most common surgical procedure is the Whipple procedure, which involves removing the head of the pancreas along with parts of the small intestine, bile duct, and sometimes the stomach. This is a complex operation that requires significant recovery time but can be life-extending for carefully selected patients. For tumors located in other parts of the pancreas, different surgical approaches may be used.
In addition to surgery, treatment for pancreatic cancer at Comprehensive Cancer Centers often includes chemotherapy, radiation therapy, or a combination of therapies. Chemotherapy uses drugs to kill rapidly dividing cancer cells, while radiation therapy uses high-energy beams to target and destroy tumor tissue. These treatments may be used before surgery to shrink tumors or after surgery to eliminate remaining cancer cells. In advanced cases, they are often used to slow disease progression and relieve symptoms.
There has been growing interest in targeted therapies and immunotherapy for pancreatic cancer. Targeted therapies focus on specific genetic mutations or pathways involved in cancer growth, offering a more personalized approach to treatment. Immunotherapy aims to harness the body’s immune system to recognize and attack cancer cells. While these approaches have shown promise in some cancers, their success in pancreatic cancer has been more limited so far, although research is ongoing.
One of the reasons pancreatic cancer is so difficult to treat is its unique tumor environment. The cancer is often surrounded by a dense layer of fibrous tissue, known as the stroma, which acts as a barrier to treatment. This makes it harder for chemotherapy drugs to reach the tumor and for immune cells to penetrate the area. Scientists are actively studying ways to overcome this barrier and improve treatment effectiveness.
Living with pancreatic cancer presents not only physical challenges but also emotional and psychological ones. The diagnosis is often associated with uncertainty and fear, given the aggressive nature of the disease. Patients may experience pain, digestive issues, and fatigue, all of which can affect quality of life. Support from healthcare providers, family, and counseling services plays a critical role in helping individuals cope with the disease and its treatment.
Nutrition is another crucial aspect of managing pancreatic cancer. Because the pancreas is involved in digestion, the disease and its treatment can interfere with the body’s ability to absorb nutrients. Patients may require enzyme replacement therapy to help digest food properly, along with dietary adjustments to maintain weight and strength. Managing blood sugar levels can also become more challenging, especially if the insulin-producing cells of the pancreas are affected.
Research into pancreatic cancer continues to move forward with scientists exploring new ways to detect the disease earlier and treat it more effectively. Liquid biopsies, which analyze cancer-related material in the blood, are being studied as a potential tool for early detection. Advances in genomics and personalized medicine are also helping researchers better understand the disease and develop more targeted therapies.
Prevention strategies focus primarily on reducing risk factors. Avoiding smoking is one of the most effective steps. Maintaining a healthy weight, managing diabetes, and following a balanced diet may also help lower risk. While not all cases can be prevented, these lifestyle choices can contribute to overall health and potentially reduce the likelihood of developing the disease.
Pancreatic cancer is a complex and aggressive disease that often develops without early warning. Its deep location in the body and subtle initial symptoms make early detection difficult, which contributes to its high mortality rate. Despite these challenges, advances in surgery, chemotherapy, and emerging therapies are gradually improving outcomes. Continued research, increased awareness, and a focus on risk reduction remain essential in the effort to better understand and combat this formidable disease.
Comprehensive Cancer Centers Can Help
Physicians at Comprehensive Cancer Centers provide a variety of treatment options for pancreatic cancer, with treatments being conducted in Southern Nevada. To schedule an appointment, please call 702-952-3350.
The content in this post is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of qualified health providers with questions you may have regarding medical conditions.